AMGN Covered Call Strategy
AMGN (Amgen Inc.), in the Healthcare sector, (Drug Manufacturers - General industry), listed on NASDAQ.
Amgen Inc., established in 1980 and headquartered in Thousand Oaks, California, is a global biotechnology leader focused on discovering, developing, manufacturing, and delivering groundbreaking human medicines. The company's scientific endeavors span several critical therapeutic categories, including inflammatory conditions, oncology and hematology, bone health, cardiovascular diseases, nephrology, and neuroscience. Its extensive portfolio features a range of significant pharmaceutical products. Notable examples include Enbrel, prescribed for conditions like plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, which helps cancer patients by reducing the risk of infection linked to a low white blood cell count; Prolia, utilized in postmenopausal women to combat osteoporosis; and Xgeva, designed to prevent skeletal-related complications. Otezla offers relief for adult patients suffering from plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease. Aranesp addresses anemia and low red blood cell counts, while KYPROLIS is employed to treat patients with relapsed or refractory multiple myeloma.
AMGN (Amgen Inc.) trades in the Healthcare sector, specifically Drug Manufacturers - General, with a market capitalization of approximately $224.62B, a trailing P/E of 25.70, a beta of 0.40 versus the broader market, a 52-week range of 269.77-421.79, average daily share volume of 2.7M, a public-listing history dating back to 1983, approximately 32K full-time employees. These structural characteristics shape how AMGN stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.40 indicates AMGN has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. AMGN pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a covered call on AMGN?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
AMGN snapshot
As of August 14, 2026, spot at $414.61, ATM IV 24.11%, IV rank 31.37%, expected move 6.91%. The covered call on AMGN below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.
Why this covered call structure on AMGN specifically: AMGN IV at 24.11% is mid-range versus its 1-year history, so the credit collected on a AMGN covered call sits in line with its long-run distribution, with a market-implied 1-standard-deviation move of approximately 6.91% (roughly $28.65 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated AMGN expiries trade a higher absolute premium for lower per-day decay. Position sizing on AMGN should anchor to the underlying notional of $414.61 per share and to the trader's directional view on AMGN stock.
AMGN covered call setup
The AMGN covered call below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With AMGN at $414.61 on that close, the first option leg uses a $435.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed AMGN chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 AMGN shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $414.61 | long |
| Sell 1 | Call | $435.00 | $3.49 |
AMGN covered call risk and reward
- Net Premium / Debit
- -$41,112.00
- Max Profit (per contract)
- $2,388.00
- Max Loss (per contract)
- -$41,111.00
- Breakeven(s)
- $411.12
- Risk / Reward Ratio
- 0.058
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
AMGN covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on AMGN. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$41,111.00 |
| $91.68 | -77.9% | -$31,943.85 |
| $183.35 | -55.8% | -$22,776.71 |
| $275.02 | -33.7% | -$13,609.56 |
| $366.70 | -11.6% | -$4,442.42 |
| $458.37 | +10.6% | +$2,388.00 |
| $550.04 | +32.7% | +$2,388.00 |
| $641.71 | +54.8% | +$2,388.00 |
| $733.38 | +76.9% | +$2,388.00 |
| $825.05 | +99.0% | +$2,388.00 |
When traders use covered call on AMGN
Covered calls on AMGN are an income strategy run on existing AMGN stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
AMGN thesis for this covered call
The market-implied 1-standard-deviation range for AMGN extends from approximately $385.96 on the downside to $443.26 on the upside. A AMGN covered call collects premium on an existing long AMGN position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether AMGN will breach that level within the expiration window. Current AMGN IV rank near 31.37% is mid-range against its 1-year distribution, so the IV signal is neutral; the covered call thesis on AMGN should anchor more to the directional view and the expected-move geometry. As a Healthcare name, AMGN options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to AMGN-specific events.
AMGN covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. AMGN positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move AMGN alongside the broader basket even when AMGN-specific fundamentals are unchanged. Short-premium structures like a covered call on AMGN carry tail risk when realized volatility exceeds the implied move; review historical AMGN earnings reactions and macro stress periods before sizing. Always rebuild the position from current AMGN chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on AMGN?
- A covered call on AMGN is the covered call strategy applied to AMGN (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With AMGN stock at $414.61 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed AMGN chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are AMGN covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the AMGN covered call priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 24.11%), the computed maximum profit is $2,388.00 per contract and the computed maximum loss is -$41,111.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a AMGN covered call?
- The breakeven for the AMGN covered call priced on this page is roughly $411.12 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The AMGN market-implied 1-standard-deviation expected move in the same options snapshot is approximately 6.91%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on AMGN?
- Covered calls on AMGN are an income strategy run on existing AMGN stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current AMGN implied volatility affect this covered call?
- AMGN ATM IV is at 24.11% with IV rank near 31.37%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.